Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review - PubMed (original) (raw)
Review
Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review
Magda Guilera et al. Am J Gastroenterol. 2005 May.
Abstract
Irritable bowel syndrome (IBS) is a heterogeneous condition characterized by the presence of abdominal discomfort or pain and bowel habit alterations: constipation (C-IBS), diarrhea (D-IBS), or alternating C and D (A-IBS). Its clinical course is poorly known.
Objectives: (i) To compare bowel habit subtypes distribution in IBS according to sample origin and diagnosis criteria; (ii) To evaluate IBS temporal patterns based on follow-up studies.
Methods: A literature search (1966-2003) was conducted in the MEDLINE and EMBASE databases. A total of 72 studies were found and 22 were finally selected.
Results: Population-based studies from the United States (Manning) found similar distribution among C-IBS, D-IBS, and A-IBS, while European studies (Rome I, Rome II, or self-reporting) showed either C-IBS or A-IBS as the most prevalent subtypes. Primary care office-based studies (Rome I or Rome II) showed A-IBS as the most prevalent group. Gastroenterology specialized office-based studies found either C-IBS or D-IBS as the most frequently reported subtype. Prospective follow-up investigations showed that the most frequent IBS temporal pattern profile consists of mild to moderate symptoms appearing in cluster in an intermittent way, about once a week, and lasting 2-5 days on average.
Conclusion: IBS clinical subtypes distribution differs depending on the population evaluated, the geographical location, and the criteria employed to define IBS and bowel habit subtypes. In most cases, clinical course is characterized by the presence of mild-to-moderate symptoms appearing sequentially. Prospective studies, using clear and stable diagnostic criteria and subtype definitions, and based on daily data collection should further characterize IBS clinical course.
Comment in
- New criteria for irritable bowel syndrome based on prospective symptom evaluation.
Walter SA, Ragnarsson G, Bodemar G. Walter SA, et al. Am J Gastroenterol. 2005 Nov;100(11):2598-9. doi: 10.1111/j.1572-0241.2005.00305_5.x. Am J Gastroenterol. 2005. PMID: 16279922 No abstract available.
Similar articles
- Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype.
Mearin F, Balboa A, Badía X, Baró E, Caldwell E, Cucala M, Díaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Mearin F, et al. Eur J Gastroenterol Hepatol. 2003 Feb;15(2):165-72. doi: 10.1097/00042737-200302000-00010. Eur J Gastroenterol Hepatol. 2003. PMID: 12560761 - Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern.
Su AM, Shih W, Presson AP, Chang L. Su AM, et al. Neurogastroenterol Motil. 2014 Jan;26(1):36-45. doi: 10.1111/nmo.12220. Epub 2013 Aug 29. Neurogastroenterol Motil. 2014. PMID: 23991913 Free PMC article. - Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study).
Garrigues V, Mearin F, Badía X, Balboa A, Benavent J, Caballero A, Domínguez E, Díaz-Rubio M, Roset M, Figueras M, Cucala M; RITMO GROUP. Garrigues V, et al. Aliment Pharmacol Ther. 2007 Feb 1;25(3):323-32. doi: 10.1111/j.1365-2036.2006.03197.x. Epub 2007 Jan 8. Aliment Pharmacol Ther. 2007. PMID: 17217445 - Irritable bowel syndrome and chronic constipation: Fact and fiction.
Bellini M, Gambaccini D, Usai-Satta P, De Bortoli N, Bertani L, Marchi S, Stasi C. Bellini M, et al. World J Gastroenterol. 2015 Oct 28;21(40):11362-70. doi: 10.3748/wjg.v21.i40.11362. World J Gastroenterol. 2015. PMID: 26523103 Free PMC article. Review. - A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation.
Johnston JM, Shiff SJ, Quigley EM. Johnston JM, et al. Curr Med Res Opin. 2013 Feb;29(2):149-60. doi: 10.1185/03007995.2012.754743. Epub 2012 Dec 20. Curr Med Res Opin. 2013. PMID: 23198977 Review.
Cited by
- Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.
Zhu S, Liu S, Li H, Zhang Z, Zhang Q, Chen L, Zhao Y, Chen Y, Gu J, Min L, Zhang S. Zhu S, et al. Front Cell Infect Microbiol. 2019 Oct 18;9:346. doi: 10.3389/fcimb.2019.00346. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31681624 Free PMC article. - Subtypes of irritable bowel syndrome in children and adolescents.
Self MM, Czyzewski DI, Chumpitazi BP, Weidler EM, Shulman RJ. Self MM, et al. Clin Gastroenterol Hepatol. 2014 Sep;12(9):1468-73. doi: 10.1016/j.cgh.2014.01.031. Epub 2014 Jan 29. Clin Gastroenterol Hepatol. 2014. PMID: 24486406 Free PMC article. - Cocultivation of Chinese prescription and intestine microbiota: SJZD alleviated the major symptoms of IBS-D subjects by tuning neurotransmitter metabolism.
Xia X, Xie Y, Chen Q, Ding D, Wang Z, Xu Y, Wang Y, Wang X, Ding W. Xia X, et al. Front Endocrinol (Lausanne). 2022 Nov 14;13:1053103. doi: 10.3389/fendo.2022.1053103. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36452327 Free PMC article. - Multi-omics Analysis of Gut Microbiota and Metabolites in Rats With Irritable Bowel Syndrome.
Liu S, Si C, Yu Y, Zhao G, Chen L, Zhao Y, Zhang Z, Li H, Chen Y, Min L, Zhang S, Zhu S. Liu S, et al. Front Cell Infect Microbiol. 2019 May 29;9:178. doi: 10.3389/fcimb.2019.00178. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31192167 Free PMC article. - Study design considerations for irritable bowel syndrome clinical trials.
Miller LE. Miller LE. Ann Gastroenterol. 2014;27(4):338-345. Ann Gastroenterol. 2014. PMID: 25330749 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical